BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7601202)

  • 1. Platelet function and fibrinolytic activity during rest and exercise in borderline hypertensive patients.
    Gleerup G; Vind J; Winther K
    Eur J Clin Invest; 1995 Apr; 25(4):266-70. PubMed ID: 7601202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinolytic activity and platelet release reaction in essential hypertension.
    Keskin A; Tombuloglu M; Büyükkeçeci F
    Jpn Heart J; 1994 Nov; 35(6):757-63. PubMed ID: 7897822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of static work on fibrinolysis and platelet function.
    Vind J; Gleerup G; Nielsen PT; Winther K
    Thromb Res; 1993 Dec; 72(5):441-6. PubMed ID: 8303686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of ageing on platelet function and fibrinolytic activity.
    Gleerup G; Winther K
    Angiology; 1995 Aug; 46(8):715-8. PubMed ID: 7639418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking further increases platelet activity in patients with mild hypertension.
    Gleerup G; Winther K
    Eur J Clin Invest; 1996 Jan; 26(1):49-52. PubMed ID: 8682155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of spirapril and hydrochlorothiazide on platelet function and euglobulin clot lysis time in patients with mild hypertension.
    Gleerup G; Petersen JR; Mehlsen J; Winther K
    Angiology; 1996 Oct; 47(10):951-5. PubMed ID: 8873580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet function and fibrinolytic activity in hypertension: differential effects of calcium antagonists and beta-adrenergic receptor blockers.
    Winther K; Gleerup G; Hedner T
    J Cardiovasc Pharmacol; 1991; 18 Suppl 9():S41-4. PubMed ID: 1725542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients.
    Rångemark C; Hedner JA; Carlson JT; Gleerup G; Winther K
    Sleep; 1995 Apr; 18(3):188-94. PubMed ID: 7610315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increase in endogenous fibrinolysis and platelet activity during exercise in young volunteers.
    Beisiegel B; Treese N; Hafner G; Meyer J; Darius H
    Agents Actions Suppl; 1992; 37():183-9. PubMed ID: 1378684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does calcium channel blockade and beta-adrenergic blockade affect platelet function and fibrinolysis to a varying degree?
    Gleerup G; Mehlsen J; Winther K
    J Cardiovasc Pharmacol; 1995 Jan; 25(1):87-9. PubMed ID: 7723358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of supine exercise on platelet aggregation and fibrinolytic activity.
    Dag B; Gleerup G; Bak AM; Hindberg I; Mehlsen J; Winther K
    Clin Physiol; 1994 Mar; 14(2):181-6. PubMed ID: 8205749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationships between serum lipids, serotonin, platelet aggregation and some fibrinolytic parameters in humans.
    Malyszko J; Urano T; Knofler R; Ihara H; Takada Y; Takada A
    Life Sci; 1994; 55(21):1619-23. PubMed ID: 7968236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced levels of tissue-type plasminogen activator in borderline hypertension.
    Wall U; Jern C; Bergbrant A; Jern S
    Hypertension; 1995 Nov; 26(5):796-800. PubMed ID: 7591020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibrinolytic system is not impaired in older men with hypertension.
    DeSouza CA; Dengel DR; Rogers MA; Cox K; Macko RF
    Hypertension; 1996 May; 27(5):1053-8. PubMed ID: 8621196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of organic nitrates on ex vivo platelet aggregation and fibrinolysis in man.
    Wolfram G; Meyer U; Scheske U; Horn M; Drummer C; Spannagl M; Gerzer R
    Eur J Med Res; 1996 Mar; 1(6):291-8. PubMed ID: 9367942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibrinolytic responses to acute physical activity in older hypertensive men.
    DeSouza CA; Dengel DR; Rogers MA; Cox K; Macko RF
    J Appl Physiol (1985); 1997 Jun; 82(6):1765-70. PubMed ID: 9173939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired fibrinolysis in hypertension and obesity due to high plasminogen activator inhibitor-1 level in plasma.
    Urano T; Kojima Y; Takahashi M; Serizawa K; Sakakibara K; Takada Y; Takada A
    Jpn J Physiol; 1993; 43(2):221-8. PubMed ID: 8355419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemostatic variables in arterial hypertension.
    Trifiletti A; Barbera N; Pizzoleo MA; Lasco A; Lucifora S; Leone G; Soraci S; Pedullà M; Frisina N
    Haemostasis; 1995; 25(5):237-40. PubMed ID: 7489962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of the plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cerebral infarction induced by the venous occlusion].
    Wakamatsu S; Banno T; Tohnai M; Oguri T
    Nihon Ronen Igakkai Zasshi; 1995; 32(8-9):566-70. PubMed ID: 8531402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrinolysis and insulin sensitivity in imidapril and candesartan (FISIC study) recipients with hypertension.
    Fogari R; Zoppi A; Salvadeo SA; Mugellini A; Lazzari P; Santoro T; Derosa G
    Hypertens Res; 2011 Apr; 34(4):509-15. PubMed ID: 21179101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.